نتایج جستجو برای: pravastatin

تعداد نتایج: 1688  

Journal: :Bioresource technology 2011
Chung-Liang Lin Ya-Li Tang Shyh-Mirn Lin

Pravastatin is one of the first available statins on the market. The purpose of this study was to isolate and identify the quinoline-degrading microorganism from petroleum-contaminated soil that could bioconvert compactin to pravastatin. There were 10,011 microorganism colonies isolated; five strains showed a higher capability for quinoline biodegradation. These five strains were evaluated for ...

Journal: :British journal of anaesthesia 2010
C C McGown N J Brown P G Hellewell C S Reilly Z L S Brookes

BACKGROUND Sepsis induces microvascular inflammation and production of the vasodilator nitric oxide (NO) via endothelial and inducible nitric oxide synthase (eNOS or NOS III and iNOS or NOS II). Statins are cholesterol-lowering drugs; however, they also attenuate inflammation. This study aimed to determine whether pravastatin protected against sepsis-induced hypotension, loss of vascular tone, ...

2017
Adelina Balan Irit Szaingurten-Solodkin Shani S Swissa Valeria Feinshtein Mahmoud Huleihel Gershon Holcberg Doron Dukler Ofer Beharier

INTRODUCTION Research in animal models and preliminary clinical studies in humans support the use of pravastatin for the prevention of preeclampsia. However, its use during pregnancy is still controversial due to limited data about its effect on the human placenta and fetus. METHODS In the present study, human placental cotyledons were perfused in the absence or presence of pravastatin in the...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2006
Oliver Hofnagel Birgit Luechtenborg Heike Eschert Gabriele Weissen-Plenz Nicholas J Severs Horst Robenek

BACKGROUND LOX-1, a receptor for oxidized low-density lipoprotein (OxLDL), seems to play a critical role in foam cell formation of macrophages (Mphis) and smooth muscle cells (SMC). Inhibition of LOX-1 expression reduces foam cell formation and might influence lipid core formation in atherosclerotic lesions. Because statins are able to downregulate LOX-1 expression in vitro, we examined if prav...

Journal: :European heart journal 2003
Gavin J Blake Michelle A Albert Nader Rifai Paul M Ridker

AIM Recent data suggests that LDL particle concentration, as determined by Nuclear Magnetic Resonance (NMR) spectroscopy, may be associated with cardiovascular risk. We sought to determine the effect of randomization to pravastatin therapy on LDL particle concentration-NMR, among a primary prevention population. METHODS AND RESULTS LDL particle concentration-NMR, LDL size-NMR, and standard ch...

2015
Amir A Zeki Jennifer M Bratt Kevin Y Chang Lisa M Franzi Sean Ott Mark Silveria Oliver Fiehn Jerold A Last Nicholas J Kenyon

Systemic treatment with statins mitigates allergic airway inflammation, TH2 cytokine production, epithelial mucus production, and airway hyperreactivity (AHR) in murine models of asthma. We hypothesized that pravastatin delivered intratracheally would be quantifiable in lung tissues using mass spectrometry, achieve high drug concentrations in the lung with minimal systemic absorption, and mitig...

Journal: :British journal of pharmacology 2000
T Kobayashi T Matsumoto K Kamata

1. We investigated the effects of chronic pravastatin treatment on the impaired endothelium-dependent relaxation seen in aortae from established streptozotocin (STZ)-induced diabetic rats. Starting at 6 weeks of diabetes, pravastatin (10 mg kg(-1)) was administered to STZ-induced diabetic rats for 4 weeks. 2. The increased total cholesterol and low-density lipoprotein (LDL) cholesterol levels s...

2014
Hae-Young Lee Hyun-Jai Cho Hee-Yul Kim Hee-Kyung Jeon Joon Han Shin Suk-Min Kang Sang Hong Baek

BACKGROUND/AIMS This study was designed to evaluate the dose-effect relationship of statins in patients with ischemic congestive heart failure (CHF), since the role of statins in CHF remains unclear. METHODS The South koreAn Pitavastatin Heart FaIluRE (SAPHIRE) study was designed to randomize patients with ischemic CHF into daily treatments of 10 mg pravastatin or 4 mg pitavastatin. RESULTS...

2005
Tsung-Ming Lee Mei-Shu Lin Tsai-Fwu Chou Chang-Her Tsai Nen-Chung Chang

Endothelin (ET)-1 has been implicated in the development of cardiac hypertrophy. We investigated the effect of pravastatin on development of ventricular hypertrophy in spontaneously hypertensive rats (SHR) and whether the attenuated hypertrophic effect was via reduced ET-1 expression. Normolipidemic SHR were treated with one of the following therapies for 8 weeks: vehicle; a nonselective ET rec...

Journal: :Bioscientia medicina 2022

Background: Preeclampsia (PE) is hypertension in pregnancy that currently occurs starting from the time of placentation and 1 five leading causes maternal death. The main cause preeclampsia placenta, which hypoxic, spiral artery remodeling fails. Hypoxia-inducible factor-1-alpha (HIF-1-A), a marker nucleus, overexpressed during tissue hypoxia. Pravastatin has pleiotropic effect as synthesis nit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید